dalteparin has been researched along with Osteoarthritis, Knee in 9 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Osteoarthritis, Knee: Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our experience with rivaroxaban in elective hip and knee arthroplasty showed no significant difference in the incidence of VTE or major bleeding." | 3.79 | Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing. ( Jeer, P; Rose, B; Saran, D; Shrivastava, R; Sindali, K; Soueid, H, 2013) |
| "Rivaroxaban does not increase the risk of hidden blood loss for TKA when compared with enoxaparin, but enoxaparin can increase the risk of dominant blood." | 1.40 | [Comparison of rivaroxaban and enoxaparin on blood loss after total knee arthroplasty]. ( Jing, J; Li, J; Yao, Y; Zhan, J; Zhou, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mihaljević, Z | 1 |
| Dimnjaković, D | 1 |
| Tripković, B | 1 |
| Buljan, M | 1 |
| Aljinović, A | 1 |
| Delimar, D | 1 |
| Bićanić, G | 1 |
| Giannoni, MF | 1 |
| Ciatti, R | 1 |
| Capoccia, L | 1 |
| Ruggiero, M | 1 |
| Dauri, M | 1 |
| Mariani, PP | 1 |
| Ng, QX | 1 |
| Seng, C | 1 |
| Ho, CYX | 1 |
| Yeo, WS | 1 |
| Sindali, K | 1 |
| Rose, B | 1 |
| Soueid, H | 1 |
| Jeer, P | 1 |
| Saran, D | 1 |
| Shrivastava, R | 1 |
| Sasaki, H | 1 |
| Ishida, K | 1 |
| Shibanuma, N | 1 |
| Tei, K | 1 |
| Tateishi, H | 1 |
| Toda, A | 1 |
| Yamashiro, Y | 1 |
| Matsumoto, T | 1 |
| Kuroda, R | 1 |
| Kurosaka, M | 1 |
| Li, J | 1 |
| Jing, J | 1 |
| Zhou, Y | 1 |
| Yao, Y | 1 |
| Zhan, J | 1 |
| Bindelglass, DF | 1 |
| Rosenblum, DS | 1 |
| Chung, LH | 1 |
| Chen, WM | 1 |
| Chen, CF | 1 |
| Chen, TH | 1 |
| Liu, CL | 1 |
| Khan, FY | 1 |
| Hassan, IF | 1 |
| Allity, MH | 1 |
| Khan, SM | 1 |
1 trial available for dalteparin and Osteoarthritis, Knee
| Article | Year |
|---|---|
Influence of Fondaparinux Versus Nadroparin Calcium Thromboprophylaxis on Clinical Parameters Following Total Knee Arthroplasty
Topics: Adult; Anticoagulants; Arthroplasty, Replacement, Knee; Factor Xa Inhibitors; Female; Fondaparinux; | 2016 |
8 other studies available for dalteparin and Osteoarthritis, Knee
| Article | Year |
|---|---|
Total knee replacement: prevention of deep-vein thrombosis using pharmacological (low-molecular-weight heparin) and mechanical (intermittent foot sole pump system) combined prophylaxis. Preliminary results.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Combined Modality Therapy; Echocardiography, | 2006 |
Enoxaparin: A cause of postoperative fever?
Topics: Aged; Animals; Anticoagulants; Arthroplasty, Replacement, Knee; Cattle; Diabetes Complications; Enox | 2018 |
Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Chemopreventi | 2013 |
Retrospective comparison of three thromboprophylaxis agents, edoxaban, fondaparinux, and enoxaparin, for preventing venous thromboembolism in total knee arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Dose-Response Relationship, Drug; Enoxaparin; | 2014 |
[Comparison of rivaroxaban and enoxaparin on blood loss after total knee arthroplasty].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Bloo | 2014 |
Neuraxial hematoma and paralysis after enoxaparin administration 3 days after attempted spinal anesthesia for total knee arthroplasty.
Topics: Aged; Anesthesia, Spinal; Anticoagulants; Arthroplasty, Replacement, Knee; Dose-Response Relationshi | 2010 |
Deep vein thrombosis after total knee arthroplasty in asian patients without prophylactic anticoagulation.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthritis, Rheumatoid; Arthroplasty, Replacement, Kn | 2011 |
Retroperitoneal hematoma following rofecoxib and enoxaparin coadministration in a patient with atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Comorbidity; Cyclooxygenase Inhibitors; Enoxaparin; Hemat | 2005 |